Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-25
1988-04-05
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 546122, 546157, C07D47104, C07D40304, A61K 3141
Patent
active
047359480
ABSTRACT:
(1H-Tetrazol-5-yl)-2(1H)-quinolones useful as antiallergic agents are described herein. The compounds are prepared by the reaction of sodium azide and ammonium chloride with an appropriate 3-cyano-2(1H)-quinolinone.
REFERENCES:
patent: 3943141 (1976-03-01), Ellis et al.
patent: 3993656 (1976-11-01), Rooney et al.
patent: 4035368 (1977-07-01), Erickson et al.
patent: 4350817 (1982-09-01), Scotese et al.
Hollrah Glennon H.
Kolano John J.
Merrell Dow Pharmaceuticals Inc.
Springer D. B.
LandOfFree
(1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and ant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and ant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and ant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2233803